UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 863

Sortiert nach

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

Oncogene, 2017-03, Vol.36 (11), p.1559-1572

2017

Volltextzugriff (PDF)

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer

Breast cancer research and treatment, 2019-07, Vol.176 (2), p.271-289

2019

Volltextzugriff (PDF)

Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression

Oncogene, 2015-10, Vol.34 (42), p.5395-5405

2015

Volltextzugriff (PDF)

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

JNCI : Journal of the National Cancer Institute, 1998-09, Vol.90 (18), p.1361-1370

1998

Volltextzugriff (PDF)

Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody

Breast cancer research and treatment, 2010-07, Vol.122 (2), p.371-380

2010

Volltextzugriff (PDF)

Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays

The Journal of pharmacology and experimental therapeutics, 2001-12, Vol.299 (3), p.849

2001

Volltextzugriff (PDF)

Expression and function of angiopoietin-1 in breast cancer

British journal of cancer, 2000-11, Vol.83 (9), p.1154-1160

2000

Volltextzugriff (PDF)

Phase II Evaluation of Thalidomide in Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2710-2717

2000

Volltextzugriff (PDF)

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome

Breast cancer research and treatment, 2017-11, Vol.166 (1), p.85-94

2017

Volltextzugriff (PDF)

Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants

Journal of clinical oncology, 2001-06, Vol.19 (12), p.3111-3116

2001

Volltextzugriff (PDF)

Digitized Mammography: a Clinical Trial of Postmenopausal Women Randomly Assigned to Receive Raloxifene, Estrogen, or Placebo

JNCI : Journal of the National Cancer Institute, 2001-01, Vol.93 (1), p.51-56

2001

Volltextzugriff (PDF)

Association of MMP-2 Activation Potential With Metastatic Progression in Human Breast Cancer Cell Lines Independent of MMP-2 Production

JNCI : Journal of the National Cancer Institute, 1993-11, Vol.85 (21), p.1758-1764

1993

Volltextzugriff (PDF)

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer

The Journal of clinical investigation, 1998-09, Vol.102 (6), p.1142-1151

1998

Volltextzugriff (PDF)

High-Dose Chemotherapy plus Autologous Bone Marrow Transplantation for Metastatic Breast Cancer

The New England journal of medicine, 2000-04, Vol.342 (15), p.1119-1120

Lippman, Marc E

2000

Volltextzugriff (PDF)

Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis

Oncogene, 1997-07, Vol.15 (4), p.423-435

1997

Volltextzugriff (PDF)

Angiopoietin-1 and Its Receptor Tie-2 Participate in the Regulation of Capillary-like Tubule Formation and Survival of Endothelial Cells

Microvascular research, 1999-11, Vol.58 (3), p.224-237

1999

Volltextzugriff (PDF)

Inhibition by Pentosan Polysulfate (PPS) of Heparin-Binding Growth Factors Released From Tumor Cells and Blockage by PPS of Tumor Growth in Animals

JNCI : Journal of the National Cancer Institute, 1992-11, Vol.84 (22), p.1716-1724

1992

Volltextzugriff (PDF)

Adjuvant Therapy for All Patients With Breast Cancer?

JNCI : Journal of the National Cancer Institute, 2001-01, Vol.93 (2), p.80-82

2001

Volltextzugriff (PDF)

Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute

Journal of clinical oncology, 1992-06, Vol.10 (6), p.976-983

1992

Volltextzugriff (PDF)

CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up

Breast cancer research and treatment, 2014-01, Vol.143 (1), p.11-18

2014

Volltextzugriff (PDF)

Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo

Cancer research (Chicago, Ill.), 1999-10, Vol.59 (20), p.5315-5322

1999

Volltextzugriff (PDF)

Breast Cancer Risk in Rats Fed a Diet High in n-6 Polyunsaturated Fatty Acids During Pregnancy

JNCI : Journal of the National Cancer Institute, 1996-12, Vol.88 (24), p.1821-1827

1996

Volltextzugriff (PDF)

BRCA1 and BRCA2 in breast cancer

Breast cancer research and treatment, 1999-03, Vol.54 (1), p.1-10

1999

Volltextzugriff (PDF)

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

Journal of cellular physiology, 1992-03, Vol.150 (3), p.534-544

1992

Volltextzugriff (PDF)

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial

Breast cancer research and treatment, 2001, Vol.65 (2), p.125-134

2001

Volltextzugriff (PDF)

1 – 25 von 863

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(799)
Mit Volltextzugriff
(730)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer

Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody

Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays

Expression and function of angiopoietin-1 in breast cancer

Phase II Evaluation of Thalidomide in Patients With Metastatic Breast Cancer

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome

Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants

Digitized Mammography: a Clinical Trial of Postmenopausal Women Randomly Assigned to Receive Raloxifene, Estrogen, or Placebo

Association of MMP-2 Activation Potential With Metastatic Progression in Human Breast Cancer Cell Lines Independent of MMP-2 Production

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer

High-Dose Chemotherapy plus Autologous Bone Marrow Transplantation for Metastatic Breast Cancer

Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis

Angiopoietin-1 and Its Receptor Tie-2 Participate in the Regulation of Capillary-like Tubule Formation and Survival of Endothelial Cells

Inhibition by Pentosan Polysulfate (PPS) of Heparin-Binding Growth Factors Released From Tumor Cells and Blockage by PPS of Tumor Growth in Animals

Adjuvant Therapy for All Patients With Breast Cancer?

Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute

CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up

Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo

Breast Cancer Risk in Rats Fed a Diet High in n-6 Polyunsaturated Fatty Acids During Pregnancy

BRCA1 and BRCA2 in breast cancer

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial

Suchergebnisse filtern